Aarey Drugs & Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 103.76 | 115.64 | 134.47 |
| Operating Expense | 100.51 | 112.30 | 131.59 |
| Net Profit | 1.37 | 0.47 | 0.72 |
| Net Profit Margin | 1.32 | 0.41 | 0.54 |
| Earning Per Share | 0.48 | 0.17 | 0.26 |
| EBIDTA | 3.25 | 3.29 | 2.50 |
| Effective Tax Rate | 10.77 | 33.33 | 10.42 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 103.76 |
| Operating Expense | 100.51 |
| Net Profit | 1.37 |
| Net Profit Margin | 1.32 |
| Earning Per Share | 0.48 |
| EBIDTA | 3.25 |
| Effective Tax Rate | 10.77 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 473.94 | 395.62 | 418.96 |
| Operating Expenses Annual | 471.04 | 391.17 | 411.24 |
| Operating Profit Annual | 12.71 | 11.42 | 10.45 |
| Interest Annual | 4.66 | 4.38 | 2.87 |
| Depreciation | 1.94 | 1.70 | 1.57 |
| Net Profit Annual | 4.02 | 4.68 | 3.77 |
| Tax Annual | 2.08 | 0.66 | 2.24 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 473.94 |
| Operating Expenses Annual | 471.04 |
| Operating Profit Annual | 12.71 |
| Interest Annual | 4.66 |
| Depreciation | 1.94 |
| Net Profit Annual | 4.02 |
| Tax Annual | 2.08 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 1.59 | 0.71 | 0.19 |
| Cash Flow from Operations | 10.30 | -2.99 | -1.28 |
| Cash Flow from Investing | -5.94 | -1.70 | 0.44 |
| Cash Flow from Financing | -4.48 | 5.58 | 1.35 |
| Cash Flow at the End | 1.47 | 1.59 | 0.71 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 1.59 |
| Cash Flow from Operations | 10.30 |
| Cash Flow from Investing | -5.94 |
| Cash Flow from Financing | -4.48 |
| Cash Flow at the End | 1.47 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 2.68 | 2.89 | 2.49 |
| PBIT Margin (%) | 2.27 | 2.46 | 2.12 |
| PBT Margin (%) | 1.78 | 1.90 | 1.38 |
| Net PROFIT Margin (%) | 0.85 | 1.18 | 0.90 |
| Return On Networth / Equity (%) | 2.96 | 3.74 | 3.26 |
| Return On Networth /Employed (%) | 6.38 | 6.09 | 6.28 |
| Return On Assets (%) | 2.38 | 2.93 | 2.66 |
| Total Debt / Equity (X) | 0.24 | 0.28 | 0.22 |
| Asset Turnover Ratio (%) | 2.81 | 2.48 | 2.96 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 2.68 |
| PBIT Margin (%) | 2.27 |
| PBT Margin (%) | 1.78 |
| Net PROFIT Margin (%) | 0.85 |
| Return On Networth / Equity (%) | 2.96 |
| Return On Networth /Employed (%) | 6.38 |
| Return On Assets (%) | 2.38 |
| Total Debt / Equity (X) | 0.24 |
| Asset Turnover Ratio (%) | 2.81 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 16.22 | 12.96 | 13.94 |
| Total Current Assets Annual | 265.61 | 282.59 | 270.61 |
| Non Current Assets Annual | 24.98 | 20.71 | 20.72 |
| Total Shareholders Funds Annual | 138.48 | 132.77 | 117.41 |
| Total Assets Annual | 290.59 | 303.29 | 291.32 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 16.22 |
| Total Current Assets Annual | 265.61 |
| Non Current Assets Annual | 24.98 |
| Total Shareholders Funds Annual | 138.48 |
| Total Assets Annual | 290.59 |
No Data Availabe
